Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Current Assets (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Current Assets data on record, last reported at $610.9 million in Q4 2025.

  • For Q4 2025, Current Assets rose 51.08% year-over-year to $610.9 million; the TTM value through Dec 2025 reached $610.9 million, up 51.08%, while the annual FY2025 figure was $610.9 million, 51.08% up from the prior year.
  • Current Assets reached $610.9 million in Q4 2025 per PRAX's latest filing, up from $273.8 million in the prior quarter.
  • Across five years, Current Assets topped out at $610.9 million in Q4 2025 and bottomed at $84.9 million in Q4 2023.
  • Average Current Assets over 4 years is $245.2 million, with a median of $223.1 million recorded in 2022.
  • Peak YoY movement for Current Assets: plummeted 59.74% in 2023, then soared 376.4% in 2024.
  • A 4-year view of Current Assets shows it stood at $110.8 million in 2022, then decreased by 23.42% to $84.9 million in 2023, then skyrocketed by 376.4% to $404.4 million in 2024, then surged by 51.08% to $610.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $610.9 million in Q4 2025, $273.8 million in Q3 2025, and $306.6 million in Q2 2025.